Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

6

Number of overlapping holdings

7.1%

% of WDNA's 90 holdings also in LFSC

20.0%

% of LFSC's 30 holdings also in WDNA

Overlap by Weight
Sector Drift (WDNA minus LFSC)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in WDNA
Weight
in LFSC
Overlap
BLUEPRINT MEDICINES CORP. 2.5% 5.6% 2.5%
BRIDGEBIO PHARMA, INC. 2.0% 5.8% 2.0%
UNITED THERAPEUTICS CORP 1.8% 1.8% 1.8%
SAREPTA THERAPEUTICS INC 1.6% 4.3% 1.6%
NEOGENOMICS INC 1.5% 3.8% 1.5%

Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to LFSC
NATERA INC 4.0%
TWIST BIOSCIENCE CORP. 3.8%
NOVOZYMES A/S-B SHARES 3.5%
VERICEL CORPORATION 2.8%
VERACYTE INC 2.5%
ELI LILLY & CO 2.3%
GERON CORP 2.1%
AGIOS PHARMACEUTICALS INC 1.9%
IOVANCE BIOTHERAPEUTICS INC 1.6%
ALNYLAM PHARMACEUTICALS INC 1.5%
WDNA Underweight Relative to LFSC
RADNET INC -7.7%
INTRA-CELLULAR THERAPIES INC -7.2%
INSMED INC -5.7%
LIVANOVA PLC -5.5%
WAVE LIFE SCIENCES LTD. -5.3%
MERIT MEDICAL SYSTEMS INC -5.1%
COLLEGIUM PHARMACEUTICAL, INC. -4.9%
SOLENO THERAPEUTICS INC -4.2%
TRAVERE THERAPEUTICS, INC. -4.1%
BRIDGEBIO PHARMA, INC. -3.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY